4-38828729-A-C

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_006068.5(TLR6):​c.745T>G​(p.Ser249Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as protective (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S249P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

TLR6
NM_006068.5 missense

Scores

19

Clinical Significance

protective no assertion criteria provided B:1

Conservation

PhyloP100: 0.928
Variant links:
Genes affected
TLR6 (HGNC:16711): (toll like receptor 6) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04555121).
BP6
Variant 4-38828729-A-C is Benign according to our data. Variant chr4-38828729-A-C is described in ClinVar as [protective]. Clinvar id is 1710535.Status of the report is no_assertion_criteria_provided, 0 stars. We mark this variant Likely_benign, oryginal submission is: [protective].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TLR6NM_006068.5 linkuse as main transcriptc.745T>G p.Ser249Ala missense_variant 2/2 ENST00000508254.6 NP_006059.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TLR6ENST00000508254.6 linkuse as main transcriptc.745T>G p.Ser249Ala missense_variant 2/21 NM_006068.5 ENSP00000424718 P1Q9Y2C9-1
TLR6ENST00000381950.2 linkuse as main transcriptc.745T>G p.Ser249Ala missense_variant 3/3 ENSP00000371376 P1Q9Y2C9-1
TLR1ENST00000506146.5 linkuse as main transcriptc.-352-23536T>G intron_variant 4 ENSP00000423725

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
49
GnomAD4 genome
Cov.:
32
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: protective
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Leprosy, susceptibility to, 1 Benign:1
protective, no assertion criteria providedcase-controlCentro Dermatológico Federico Lleras Acosta, Hospital Universitario Centro Dermatológico Federico Lleras AcostaJun 10, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
5.2
DANN
Benign
0.60
DEOGEN2
Benign
0.080
T;T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.47
T;.;T
M_CAP
Benign
0.0064
T
MetaRNN
Benign
0.046
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.49
N;N;N
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.42
N;N;.
REVEL
Benign
0.062
Sift
Benign
1.0
T;T;.
Sift4G
Benign
0.78
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.097
MutPred
0.49
Loss of loop (P = 0.2237);Loss of loop (P = 0.2237);Loss of loop (P = 0.2237);
MVP
0.26
MPC
0.13
ClinPred
0.023
T
GERP RS
3.5
Varity_R
0.021
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5743810; hg19: chr4-38830350; API